Tagged with M

Regulation Dominique Martin, CEO of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé) provides a fascinating insight into the French process of authorizing drugs and medical products, his commitment to increased transparency and increased efficiency, and the opportunity for France to take the lead in European…

Turkey Ece Kaşıkçı, General Manager, Bristol-Myers Squibb (BMS) Turkey, outlines how BMS’ groundbreaking immuno-oncology therapy has proudly become the first product of its kind to be registered and reimbursed in the country. She also highlights the company’s collaborative approach to reach this remarkable milestone. Ece also discusses her vision for BMS…

Spain Ignacio Vega and Carlos Ibares Sanz of Spanish medtech Cardiva, explain the group’s origins as a distributor, the growing importance of manufacturing, and the company’s international ambitions.   How has Cardiva evolved since its formation in Bilbao in 1989? Ignacio Vega (IV): Cardiva began life as a distributor, primarily for…

Hong Kong Bobby Liu of Milton Holdings International outlines the company’s evolution in the plastics and packaging industry and the specialized services it provides to clients in medtech and pharmaceuticals.   What is the story behind the creation of the company and how did you find such a niche in the market?…

regulation Chinese ecommerce behemoths Alibaba and JD.com are being used to buy and sell tens of thousands of prescription medicines, skirting regulations in what is a legal grey area. According to a recent Financial Times report, dozens of listings from third party vendors – mainly pharmacies – for drugs such as…

Turkey With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between the West and the East. Hakan Yurdakul, head of economy monitoring and coordination at the Presidency Office is bullish, “The…

Hong Kong Laurence Frémy, director for APAC at Laboratoires Expanscience, discusses emerging skincare and dermatology trends in the region and her priorities for the affiliate.   Having had the experience of opening the affiliate in Brazil, in addition to your in-depth understanding of other emerging markets, what were the key skills you…

Portugal Santiago Ruiz, entering his fourth year leading B. Braun’s Portuguese affiliate in Lisbon, highlights the innovation present in Portugal, B. Braun’s Vision 2020 and emerging trends in the medtech world.   How has the affiliate evolved over the past three years under your management? We faced two crucial challenges over…

Hong Kong Zuellig Pharma’s Andi Umbricht discusses the distributor’s deep commitment to Asia, the adoption of new technologies, and emerging trends within the Hong Kong and Asian distribution markets. Zuellig Pharma has a long tradition in Asia. What capabilities have you developed over the years in the region? Zuellig Pharma started operations…

Algeria Mourad Belkheyar, acting director general of Varian Healthcare Algeria lifts the lid on the progress Algeria has made in its quest to bring the most advanced radiotherapies to Algeria. He discusses the critical role of Varian healthcare in training engineers, operating, and maintaining such complex machinery, to improve the prognosis…

Hong Kong Frederic Charles, CEO of Pierre Fabre Hong Kong and Macau, outlines brand perceptions of Pierre Fabre’s dermatological products in Hong Kong, e-commerce, and other emerging skincare trends in Asia.   With the opening of Pierre Fabre Hong Kong affiliate in 2016, what were the main achievements so far? The affiliate…

Hong Kong Benjamin Chan of MediConcepts – a Hong Kong-based medtech CDMO – outlines the potential impact of the Greater Bay Area Initiative on Hong Kong medtech, and the key factors behind his company’s success.   Benjamin, as an industry veteran within the Hong Kong medical devices sector, with also a factory…